RNS Number : 6311I Renalytix PLC 13 August 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 13 August 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000
RNS Number : 9108H Renalytix PLC 06 August 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 6 August 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000
RNS Number : 2696H Renalytix PLC 02 August 2021 Renalytix plc (" Renalytix " or the " Company ") Total voting rights New York , 2 August 2021 - Renalytix (LSE: RENX) announces that t he Company's total issued share capital consists of 72,229,786 shares of 0.25 pence each, with each
RNS Number : 1332H Renalytix PLC 30 July 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 30 July 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O . James Sterling , the Company's Chief Financial Officer, of 12,000
Berman serves on the board of Loews Corporation, is a member of the board of trustees of Beth Israel Deaconess, and is a former chief financial officer of Harvard University NEW YORK and SALT LAKE CITY, July 28, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the
RNS Number : 6767G Renalytix PLC 28 July 2021 Renalytix Appoints Ann Berman to its Board of Directors Berman serves on the board of Lowes Corporation , is a member of the board of trustees of Beth Israel Deaconess , and is a former chief financial officer of Harvard University NEW YORK
NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the company will be presenting at the upcoming 41 st Annual Canaccord Genuity Virtual Global Growth Conference. Renalytix’s management is scheduled to present at the
RNS Number : 3061G Renalytix PLC 23 July 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 23 July 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000
Hutson to Build on Renalytix Quality and Regulatory Strategy for KidneyIntelX Global Commercialization NEW YORK and SALT LAKE CITY, July 22, 2021 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Joseph Hutson as its Vice President of Quality and
RNS Number : 0685G Renalytix PLC 22 July 2021 Renalytix plc (" Renalytix " or the " Company ") Renalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory Hutson To Build-on Renalytix Quality and Regulatory Strategy for KidneyIntelX Global Commercialization NEW YORK
